{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:55:48Z","timestamp":1790207748573,"version":"4.1.0"},"reference-count":21,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2026.295","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:51:43Z","timestamp":1767955903000},"page":"1-7","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal treatment and tumour biology\u2011driven long\u2011term survival in PSC\u2011associated hilar cholangiocarcinoma: A case report"],"prefix":"10.3892","volume":"6","author":[{"given":"Evangelia","family":"Florou","sequence":"first","affiliation":[{"name":"Institute of Liver Studies, Department of Hepato\u2011Pancreato\u2011Biliary Surgery, King's College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, Department of General Hepatology and Liver Transplantation, King's College Hospital London, London SE5 9RS, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Sarker","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, Department of Oncology, King's College Hospital London, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthi","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, Department of Hepato\u2011Pancreato\u2011Biliary Surgery, King's College Hospital, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Prachalias","sequence":"additional","affiliation":[{"name":"Hepato\u2011Pancreato\u2011Biliary Surgery and Liver Transplantation, London Bridge Hospital, London SE1 2PR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"key20260202122653_b1-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1245\/s10434-021-09871-6","article-title":"The landmark series: Hilar cholangiocarcinoma","volume":"28","author":"Soares","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"key20260202122653_b2-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20260202122653_b3-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver transplantation for peri-hilar cholangiocarcinoma","volume":"24","author":"Tan","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"e100045","key":"key20260202122653_b4-MI-6-1-00295","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2023-100045","article-title":"Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: A comprehensive review","volume":"2","author":"Villard","year":"2024","journal-title":"eGastroenterology"},{"key":"key20260202122653_b5-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00268-016-3551-9","article-title":"Actual long-term survival outcome of 403 consecutive patients with hilar cholangiocarcinoma","volume":"40","author":"Kang","year":"2016","journal-title":"World J Surg"},{"key":"key20260202122653_b6-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"key":"key20260202122653_b7-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: A definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"key20260202122653_b8-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","article-title":"The \u201850-50 criteria\u2019 on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy","volume":"242","author":"Balzan","year":"2005","journal-title":"Ann Surg"},{"key":"key20260202122653_b9-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.transproceed.2025.02.001","article-title":"Transplantation for peri-hilar and intrahepatic cholangiocarcinoma with mTOR immunosuppression","volume":"57","author":"Semaan","year":"2025","journal-title":"Transplant Proc"},{"issue":"101875","key":"key20260202122653_b10-MI-6-1-00295","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101875","article-title":"Long-term morbidity after surgery for perihilar cholangiocarcinoma: A cohort study","volume":"45","author":"Gilbert","year":"2022","journal-title":"Surg Oncol"},{"issue":"2389","key":"key20260202122653_b11-MI-6-1-00295","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102389","article-title":"Impact of positive lymph nodes and resection margin status on the overall survival of patients with resected perihilar cholangiocarcinoma: The ENSCCA registry","volume":"14","author":"Nooijen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260202122653_b12-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4291\/wjgp.v12.i5.84","article-title":"Cholangiocarcinoma and liver transplantation: What we know so far?","volume":"12","author":"Safarpour","year":"2021","journal-title":"World J Gastrointest Pathophysiol"},{"key":"key20260202122653_b13-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J Am Coll Surg"},{"key":"key20260202122653_b14-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12328-013-0432-8","article-title":"Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: Report of a case","volume":"6","author":"Ota","year":"2013","journal-title":"Clin J Gastroenterol"},{"issue":"4947","key":"key20260202122653_b15-MI-6-1-00295","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15204947","article-title":"Primary sclerosing cholangitis-associated cholangiocarcinoma: From pathogenesis to diagnostic and surveillance strategies","volume":"15","author":"Catanzaro","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20260202122653_b16-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S1470-2045(23)00242-5","article-title":"Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study","volume":"24","author":"Harding","year":"2023","journal-title":"Lancet Oncol"},{"key":"key20260202122653_b17-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1634\/theoncologist.2019-0922","article-title":"HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer","volume":"25","author":"Vivaldi","year":"2020","journal-title":"Oncologist"},{"key":"key20260202122653_b18-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"e1893","DOI":"10.1002\/onco.13884","article-title":"Limited Impact of HER2 Expression on Survival Outcomes in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection","volume":"26","author":"Hori","year":"2021","journal-title":"Oncologist"},{"key":"key20260202122653_b19-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"e1051","DOI":"10.1093\/oncolo\/oyae076","article-title":"EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer and their prognostic significance","volume":"29","author":"Kim","year":"2024","journal-title":"Oncologist"},{"issue":"3052","key":"key20260202122653_b20-MI-6-1-00295","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17183052","article-title":"Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies","volume":"17","author":"Oura","year":"2025","journal-title":"Cancers (Basel)"},{"key":"key20260202122653_b21-MI-6-1-00295","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","article-title":"Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma","volume":"120","author":"Goeppert","year":"2019","journal-title":"Br J Cancer"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:26:59Z","timestamp":1770028019000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2026.295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,9]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2026.295","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}